Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
about
Gene-environment interaction and risk of breast cancerBreastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysisLifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.High mobility group box-1 and its clinical value in breast cancer.Breast cancer risks and risk prediction models.Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survivalMutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.Gene-panel sequencing and the prediction of breast-cancer risk.Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.Breast cancer under age 40: a different approach.Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.Hormonal contraception and breast cancer, what more do we need to know?Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells.Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells.Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.Commentary on changing the risk threshold for surgical prevention of ovarian cancer.Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.Living With Genetic Vulnerability: a Life Course Perspective.The potential contribution of dietary factors to breast cancer prevention.Ovarian Cancer Prevention in High-risk Women.Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers.Smoking and risk of breast cancer in the Generations Study cohort.Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis.Genetic testing in women with breast cancer: implications for treatment.Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women.The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Modifiable Lifestyle Factors: Opportunities for (Hereditary) Breast Cancer Prevention - a Narrative ReviewReducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect
P2860
Q26772236-B5F5EFE0-D218-415F-A8E2-CBD497F7ED22Q28085555-1ACDB866-8A6C-44C9-BD5F-CEB0F313ADF3Q33885464-C1E547AD-3704-47E3-8658-E2CE5AB2C376Q34789523-9CD3EC72-CFF8-45DD-8F76-5CAF6E0CF10CQ35101004-22575954-93B4-452E-9969-966BFB2BDB20Q35399596-121F88BC-A0B8-47FB-9324-22A2985E7E92Q35690548-B8C5AD6A-2DAC-48C9-8EEE-EC8B2E012907Q35809413-8CC057A8-F102-4DCE-BD9E-1CF724CF4FABQ35869326-BF8F20BE-F7C5-4DDA-BFB0-F29581068499Q36175072-EB1D436C-63B3-4CA8-8B3E-18C67B9DD77BQ36178189-FEDA5BF4-5539-4969-8370-74D543D94BE1Q36256006-ADC8BB76-BEF0-4AF6-8268-FB072E289475Q37360550-DC4B506E-AD2D-47E9-B3B5-3CFBBA5C19C5Q37401308-91A545E2-1250-4E08-976C-25360815BADBQ37702214-227A389D-B9E5-4C99-9BB9-590DD6E4DCC8Q37705926-15427C71-7BA9-493A-B1ED-B324AA6974CEQ38386346-413C756B-DB41-452A-923E-2ACBA65950BDQ38454309-84B53B1A-37F6-4497-A5B9-96A514D373E0Q38609944-1F268100-ACE3-42DF-9F66-9EF2EA14D2EDQ38714408-78D6B45E-3BF1-49B3-B092-61D64FCF7451Q38732720-E26D6444-95FE-4A65-B72B-A7CF5B6C7838Q38733762-91A44D90-D1BE-444A-8208-EA6749448046Q38874006-B8038553-7A79-4AD0-9FB3-C6E5B2BE8ABDQ38933663-E0011664-261F-491C-AC14-E8D503B91F89Q39126005-EBD763F2-2A4F-468C-BB6E-154B1E7CC778Q39209405-100452F6-BF7F-45BC-A581-3C24D55529DAQ39214999-30B51003-2E08-4C34-95AD-BCC288FEE256Q40081082-E881DA37-6438-42E5-83E0-C07353C1411EQ40590078-926E542C-16C9-4791-A57E-D463BCA1188CQ41358003-E5830417-3F40-49CE-B907-597B0877B48DQ45068704-991B85AA-9399-42BE-A848-52E003E1AF49Q47160276-FA98CA55-86E3-4D3C-9BF2-FD4A8535C311Q47162371-94A17994-0AE2-490D-A28E-90702440C06CQ47870328-4A25E0D2-1508-4D5F-BD10-651225ECB086Q47884776-5EE6AC2B-CFCA-45CF-9C38-277A16DD7B83Q51109209-0E5AE520-4550-421C-9C17-D61D61FE63A7Q52633981-04882DB4-6FAE-4EEF-96DD-4AA5BB25B3A4Q52684293-77C79367-31E4-45A8-9BE1-6BB6ED16B14BQ57113809-DD2565A4-30D6-4BC8-827D-2AB0447DB375Q57137351-869E008B-FAAC-4D53-ACB5-2F4EC87328CF
P2860
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@ast
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@en
type
label
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@ast
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@en
prefLabel
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@ast
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@en
P2860
P356
P1476
Modifiers of cancer risk in BR ...... atic review and meta-analysis.
@en
P2093
Tara M Friebel
Timothy R Rebbeck
P2860
P304
P356
10.1093/JNCI/DJU091
P407
P577
2014-06-01T00:00:00Z